Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation
暂无分享,去创建一个
K. Wilms | D. Niethammer | H. Link | V. Neef
[1] R. Nuscher,et al. Bone marrow transplantation. , 1977, The American journal of nursing.
[2] D. Niethammer,et al. Uromitexan® bei hochdosierter Endoxan®-Therapie im Rahmen der Knochenmarktransplantation , 1980 .
[3] J. Pohl. Toxikologie, Pharmakokinetik und Interaktionen von Uromitexan® , 1980 .
[4] R. Voigtmann,et al. Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results. , 1979, Cancer treatment reports.
[5] N. Brock,et al. Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide. , 1979, Arzneimittel-Forschung.
[6] Clift,et al. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. , 1976, Blood.
[7] R Storb,et al. Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.